Large weight loss may lower blood sugar and inflammation
The drug "Retatrutide," known as a "giant" in weight loss medications, has shown promising results in improving blood sugar levels, reducing inflammation, and decreasing body weight by a quarter, according to the largest study of its kind. The study, which involved over 2,000 patients with obesity and type 2 diabetes, found that different doses of the drug led to significant weight loss, with participants who received a 12 mg dose losing approximately 18.8% of their body weight, along with substantial improvements in blood sugar regulation and a reduction in cardiovascular risk factors. The medication works by mimicking three main gut hormones that regulate appetite and blood sugar levels, and it also interacts with glucagon receptors to increase energy expenditure. The results, announced at the Milan conference, suggest its potential to help patients shed large amounts of excess weight and improve their health, although the drug has not yet received regulatory approval.
Notice: This Is an AI-Generated Summary
Comments (0)